Finally, colorectal cancer cells with no mutations in the B-Raf or K-Ras genes (HCA7, CaCo2, COLO320DM) show intrinsic resistance to the highly potent, selective and ATP uncompetitive inhibitor of MEK1/2 kinases selumetinib [36]. The gene discussed is BRAF; the disease is colorectal cancer.